Belgium· BE-AMP-SAM507466-00

Kisplyx 10 mg

A lenvatinib product containing lenvatinib mesilate, registered in Belgium by Eisai. The same ATC class is registered in 15 of our 19 countries.

ATC L01EX08

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lenvatinib mesilateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lenvatinib is registered in 15 of 19 countries.

Countries holding a registration under ATC L01EX08 (lenvatinib), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search lenvatinib products by name

Lenvatinib · ATC L01EX08

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lenvatinib costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Lenvatinib · price per daily dose (20 mg)

USD · FX 28 Sept 2026

CH Switzerland$297.39

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Lenvatinib Mesilate
Manufacturer: Eisai
Country: Belgium (BE)
ATC code: L01EX08
ATC class: Lenvatinib
Defined daily dose: 20 mg, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
4618690
be_apb
7738941

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

315 interactions on record for lenvatinib.

Graded by severity as the source publishes them — 81 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lenvatinib against other medicines How interaction checks work

Lenvatinib · interactions on record

315 records

81 severe
230 moderate
4 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
QuinidineC01BA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lenvatinib in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lenvatinib products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Lenvatinib Accord, Lenvatinib Rcc Sandoz
Bulgaria · Ленватиниб Виатрис
Cyprus · Lenvatinib Remedica
Czechia · Lenvatinib Accord, Lenvatinib Sandoz
Germany · Lenvatinib Accord, Lenvatinib Hexal
Denmark · Lenvatinib Accord, Lenvatinib Sandoz
Estonia · Lenvatinib Remedica, Lenvatinib Sandoz
Spain · Lenvatinib Accord, Lenvatinib Sandoz
Finland · Ixedafin, Lenvatinib
France · Lenvatinib Accord, Lenvatinib Biogaran
United Kingdom (Northern Ireland) · Lenvatinib, Lenvatinib Thornton & Ross
Greece · Kynvalib, Lenvatinib Elpen
Croatia · Lenvatinib Remedica
Hungary · Lenvatinib Stada
Ireland · Lenvatinib Accord, Lenvatinib Stada
Iceland · Kisplyx, Lenvima
Italy · Lenvatinib Accord, Lenvatinib Sandoz
Liechtenstein · Kisplyx, Lenvima
Lithuania · Lenvatinib Sandoz, Lenvatinib Stada
Luxembourg · Ixedafin, Lenvatinib Olpha
Latvia · Lenvatinib Sandoz, Lenvatinib Stada
Malta · Lenvatinib Remedica, Lenvatinib Stada
Netherlands · Lenvatinib 1a Pharma, Lenvatinib Accord
Norway · Kisplyx, Lenvatinib Accord
Portugal · Lenvatinib Accord, Lenvatinib Sandoz
Sweden · Lenvatinib Accord, Lenvatinib Avansor
Slovenia · 10 Mg, Lenvatinib Sandoz
Slovakia · Lenvatinib Pharmevid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c1eceff2-1678-4a57-8ad5-f6e3ee842650
GET /v1/drugs/c1eceff2-1678-4a57-8ad5-f6e3ee842650?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Kisplyx 10 mg",
  "name_fr": "Kisplyx 10 mg",
  "name_nl": "Kisplyx 10 mg",
  "amp_code": "SAM507466-00",
  "strengths": [
    "10.0000",
    "10.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Lenvatinib Mesilate",
    "Lenvatinib",
    "Mannitol",
    "Potassium Hydroxide",
    "Propylene Glycol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Lenvatinib",
  "authorisation_numbers": [
    "EU/1/16/1128/002",
    "EU/1/16/1128/006",
    "EU/1/16/1128/005"
  ]
}

API reference MCP server Plans

See everything about lenvatinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console